San Francisco Sentry Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $543K | Sell |
13,873
-6,795
| -33% | -$264K | 0.28% | 97 |
|
|
2021
Q1 | $749K | Sell |
20,668
-11,983
| -37% | -$425K | 0.32% | 89 |
|
|
2020
Q4 | $1.2M | Buy |
32,651
+13,692
| +72% | +$502K | 0.56% | 38 |
|
|
2020
Q3 | $660K | Sell |
18,959
-398
| -2% | -$14K | 0.34% | 80 |
|
|
2020
Q2 | $600K | Buy |
19,357
+543
| +3% | +$18.4K | 0.32% | 85 |
|
|
2020
Q1 | $583K | Sell |
18,814
-2,102
| -10% | -$71.6K | 0.37% | 70 |
|
|
2019
Q4 | $778K | Sell |
20,916
-9,744
| -32% | -$347K | 0.35% | 70 |
|
|
2019
Q3 | $1.04M | Buy |
30,660
+2,152
| +8% | +$78.3K | 0.48% | 46 |
|
|
2019
Q2 | $1.17M | Buy |
28,508
+4,612
| +19% | +$183K | 0.54% | 45 |
|
|
2019
Q1 | $963K | Buy |
23,896
+1,849
| +8% | +$74K | 0.42% | 53 |
|
|
2018
Q4 | $913K | Buy |
22,047
+303
| +1% | +$12.6K | 0.43% | 41 |
|
|
2018
Q3 | $910K | Buy |
21,744
+1,419
| +7% | +$54.6K | 0.34% | 51 |
|
|
2018
Q2 | $699K | Buy |
20,325
+315
| +2% | +$10.8K | 0.29% | 57 |
|
|
2018
Q1 | $674K | Sell |
20,010
-807
| -4% | -$27.7K | 0.19% | 104 |
|
|
2017
Q4 | $715K | Buy |
20,817
+2,861
| +16% | +$97.6K | 0.21% | 103 |
|
|
2017
Q3 | $609K | Buy |
17,956
+1,650
| +10% | +$53K | 0.2% | 117 |
|
|
2017
Q2 | $520K | Buy |
16,306
+9,906
| +155% | +$312K | 0.19% | 114 |
|
|
2017
Q1 | $208K | Sell |
6,400
-84
| -1% | -$2.65K | 0.11% | 185 |
|
|
2016
Q4 | $200K | Sell |
6,484
-29,718
| -82% | -$907K | 0.12% | 178 |
|
|
2016
Q3 | $1.16M | Sell |
36,202
-150
| -0.4% | -$5.02K | 0.69% | 44 |
|
|
2016
Q2 | $1.21M | Sell |
36,352
-2,270
| -6% | -$72.4K | 0.75% | 43 |
|
|
2016
Q1 | $1.09M | Buy |
38,622
+3,910
| +11% | +$112K | 0.65% | 46 |
|
|
2015
Q4 | $1.06M | Buy |
34,712
+131
| +0.4% | +$4.12K | 0.67% | 47 |
|
|
2015
Q3 | $1.03M | Sell |
34,581
-56
| -0.2% | -$1.8K | 0.73% | 41 |
|
|
2015
Q2 | $1.1M | Buy |
34,637
+572
| +2% | +$18.6K | 0.66% | 45 |
|
|
2015
Q1 | $1.12M | Buy |
34,065
+20
| +0.1% | +$636 | 0.67% | 42 |
|
|
2014
Q4 | $1.01M | Sell |
34,045
-4,165
| -11% | -$119K | 0.58% | 47 |
|
|
2014
Q3 | $1.07M | Buy |
38,210
+317
| +0.8% | +$8.9K | 0.54% | 45 |
|
|
2014
Q2 | $1.07M | Sell |
37,893
-74,713
| -66% | -$2.13M | 0.51% | 49 |
|
|
2014
Q1 | $3.43M | Buy |
112,606
+80
| +0.1% | +$2.38K | 1.1% | 13 |
|
|
2013
Q4 | $3.27M | Buy |
112,526
+248
| +0.2% | +$7.22K | 1.13% | 15 |
|
|
2013
Q3 | $3.06M | Sell |
112,278
-1,200
| -1% | -$32.7K | 1.15% | 12 |
|
|
2013
Q2 | $3.02M | Buy |
+113,478
| New | +$3.14M | 1.09% | 17 |
|
Other funds holding PFE
San Francisco Sentry Investment Group's PFE Position: Q2 2021 in Review
San Francisco Sentry Investment Group reduced its Pfizer (PFE) stake by 33% in Q2 2021, selling an estimated $264K and leaving 13,873 shares worth $543K. The position accounts for 0.28% of the portfolio, ranked #97.
San Francisco Sentry Investment Group first reported a position in PFE in Q2 2013 and has held it in 33 quarters since. The position peaked at $3.43M in Q1 2014. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- San Francisco Sentry Investment Group held 13,873 shares of Pfizer worth $543K as of Q2 2021.
- San Francisco Sentry Investment Group sold 6,795 Pfizer shares in Q2 2021, an estimated $264K.
- Pfizer made up 0.28% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #97 holding.
- San Francisco Sentry Investment Group first reported a position in Pfizer in Q2 2013 and has held it in 33 quarters since.
- San Francisco Sentry Investment Group's Pfizer position peaked at $3.43M in Q1 2014.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.